Us Bancorp \De\ Global Blood Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$32.4 - $68.18 $324 - $681	10 Added 22.73%	54 $4,000
Q2 2022 Aug 01, 2022	SELL	$22.3 - $37.39 $8,005 - $13,423	-359 Reduced 89.08%	44 $1,000
Q1 2022 May 11, 2022	SELL	$25.68 - $35.59 $21,571 - $29,895	-840 Reduced 67.58%	403 $14,000
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $3,535 - $5,716	-142 Reduced 10.25%	1,243 $37,000
Q3 2021 Nov 10, 2021	BUY	$25.48 - $37.34 $12,179 - $17,848	478 Added 52.7%	1,385 $36,000
Q2 2021 Aug 05, 2021	BUY	$32.46 - $43.42 $21,228 - $28,396	654 Added 258.5%	907 $32,000
Q1 2021 Apr 28, 2021	SELL	$38.94 - $50.85 $5,957 - $7,780	-153 Reduced 37.68%	253 $10,000
Q4 2020 Feb 04, 2021	SELL	$37.65 - $63.77 $40,210 - $68,106	-1,068 Reduced 72.46%	406 $18,000
Q3 2020 Nov 10, 2020	BUY	$52.76 - $74.49 $1,899 - $2,681	36 Added 2.5%	1,474 $81,000
Q2 2020 Aug 07, 2020	BUY	$48.73 - $81.82 $33,769 - $56,701	693 Added 93.02%	1,438 $91,000
Q1 2020 May 13, 2020	SELL	$41.72 - $87.2 $458 - $959	-11 Reduced 1.46%	745 $38,000
Q4 2019 Feb 04, 2020	BUY	$45.7 - $81.86 $34,046 - $60,985	745 Added 6772.73%	756 $60,000
Q3 2019 Nov 08, 2019	BUY	$45.35 - $57.91 $498 - $637	11 New	11 $1,000
Q2 2019 Aug 13, 2019	SELL	$52.6 - $63.29 $10,993 - $13,227	-209 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$39.99 - $53.48 $10,277 - $13,744	-257 Reduced 55.15%	209 $11,000
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $16,684 - $24,688	-529 Reduced 53.17%	466 $19,000
Q2 2018 Aug 08, 2018	BUY	$38.7 - $50.15 $38,506 - $49,899	995 New	995 $45,000
Q1 2018 May 08, 2018	SELL	$39.6 - $65.9 $6,415 - $10,675	-162 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$29.7 - $45.7 $4,811 - $7,403	162	162 $6,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account